X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (242) 242
Publication (22) 22
Book Review (16) 16
Conference Proceeding (11) 11
Patent (8) 8
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (137) 137
humans (127) 127
female (109) 109
risk factors (83) 83
middle aged (75) 75
medicine, general & internal (62) 62
aged (60) 60
postmenopausal women (58) 58
abridged index medicus (51) 51
women (50) 50
health aspects (47) 47
postmenopause (40) 40
risk (39) 39
estrogen (35) 35
male (33) 33
cardiovascular disease (32) 32
peripheral vascular disease (32) 32
randomized controlled-trial (31) 31
cardiac & cardiovascular systems (29) 29
clinical trials (29) 29
estrogen plus progestin (28) 28
hormone replacement therapy (28) 28
hormone therapy (28) 28
mortality (28) 28
research (28) 28
prevention (27) 27
menopause (26) 26
coronary disease - prevention & control (25) 25
coronary heart disease (24) 24
follow-up studies (24) 24
obstetrics & gynecology (24) 24
estrogen replacement therapy - adverse effects (23) 23
women's health (22) 22
womens health (22) 22
cardiovascular diseases (21) 21
cholesterol (21) 21
proportional hazards models (21) 21
adult (20) 20
cardiovascular-disease (20) 20
coronary disease - epidemiology (20) 20
coronary-heart-disease (20) 20
replacement therapy (20) 20
article (19) 19
breast cancer (19) 19
epidemiology (19) 19
estrogen replacement therapy (17) 17
estrogens, conjugated - adverse effects (17) 17
myocardial-infarction (17) 17
public, environmental & occupational health (17) 17
atherosclerosis (16) 16
care and treatment (16) 16
estrogens - therapeutic use (16) 16
stroke (16) 16
cancer (15) 15
disease (15) 15
prospective studies (15) 15
risk assessment (15) 15
coronary disease - blood (14) 14
diet (14) 14
estrogens, conjugated - therapeutic use (14) 14
hysterectomy (14) 14
incidence (14) 14
treatment outcome (14) 14
united states - epidemiology (14) 14
analysis (13) 13
cholesterol - blood (13) 13
coronary heart-disease (13) 13
south africa (13) 13
breast neoplasms - epidemiology (12) 12
cardiovascular diseases - prevention & control (12) 12
case-control studies (12) 12
cholesterol, ldl - blood (12) 12
heart-disease (12) 12
hematology (12) 12
intervention (12) 12
medroxyprogesterone acetate - adverse effects (12) 12
metaanalysis (12) 12
randomized controlled trials as topic (12) 12
therapy (12) 12
adolescent (11) 11
endocrinology & metabolism (11) 11
genetics & heredity (11) 11
age factors (10) 10
breast-cancer (10) 10
cohort studies (10) 10
double-blind method (10) 10
medical research (10) 10
sex factors (10) 10
stroke - epidemiology (10) 10
animals (9) 9
benefits (9) 9
biomarkers - blood (9) 9
cholesterol, hdl - blood (9) 9
conjugated equine estrogens (9) 9
drug therapy (9) 9
genetics (9) 9
health risk assessment (9) 9
time factors (9) 9
blood-pressure (8) 8
c-reactive protein (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2007, Volume 356, Issue 25, pp. 2591 - 2602
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2003, Volume 349, Issue 6, pp. 523 - 534
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 2013, Volume 310, Issue 13, pp. 1353 - 1368
IMPORTANCE Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention. OBJECTIVE... 
BREAST-CANCER | INSOMNIA RATING-SCALE | MEDICINE, GENERAL & INTERNAL | REPLACEMENT THERAPY | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | MILD COGNITIVE IMPAIRMENT | POSTMENOPAUSAL WOMEN | CONJUGATED EQUINE ESTROGEN | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Coronary Disease - epidemiology | Risk | Hormone Replacement Therapy - adverse effects | Pulmonary Embolism - epidemiology | Estrogens - adverse effects | Medroxyprogesterone Acetate - adverse effects | Postmenopause | Female | Stroke - epidemiology | Drug Therapy, Combination | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Estrogens, Conjugated (USP) - administration & dosage | Treatment Outcome | Endometrial Neoplasms - epidemiology | Hip Fractures - epidemiology | Breast Neoplasms - prevention & control | Coronary Disease - prevention & control | Quality of Life | Aged | Medroxyprogesterone Acetate - administration & dosage | Estrogens, Conjugated (USP) - adverse effects | Estrogens - administration & dosage | Women | Care and treatment | Research | Hormone therapy | Health aspects | Menopause | Womens health | Estrogen | Endocrine therapy | Clinical trials | Cardiovascular disease | Breast cancer | Progesterone | Index Medicus | Abridged Index Medicus
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2017, Volume 318, Issue 10, pp. 927 - 938
Journal Article
Osteoporosis International, ISSN 0937-941X, 2/2013, Volume 24, Issue 2, pp. 567 - 580
The Women's Health Initiative (WHI) double-blind, placebo-controlled clinical trial randomly assigned 36,282 postmenopausal women in the U.S. to 1,000 mg... 
Fractures | Medicine & Public Health | Calcium | Vitamin D | Orthopedics | Gynecology | Health risks and benefits | Rheumatology | Cardiovascular disease | Endocrinology | Cancer | ISCHEMIC-HEART-DISEASE | POSTMENOPAUSAL HORMONE-THERAPY | BASE-LINE CHARACTERISTICS | BREAST-CANCER | COLORECTAL-CANCER | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | POTASSIUM | CALCIUM/VITAMIN-D SUPPLEMENTATION | ESTROGEN PLUS PROGESTIN | PARTICIPANTS | Osteoporosis, Postmenopausal - epidemiology | Risk Assessment - methods | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Neoplasms - prevention & control | Urinary Calculi - chemically induced | Cholecalciferol - administration & dosage | Cholecalciferol - therapeutic use | Hip Fractures - prevention & control | Cardiovascular Diseases - epidemiology | Female | Cholecalciferol - adverse effects | Calcium Carbonate - administration & dosage | Dietary Supplements - adverse effects | Osteoporotic Fractures - epidemiology | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Calcium Carbonate - therapeutic use | Hip Fractures - etiology | Urinary Calculi - epidemiology | Bone Density Conservation Agents - administration & dosage | Hip Fractures - epidemiology | Calcium Carbonate - adverse effects | Osteoporosis, Postmenopausal - drug therapy | Aged | Neoplasms - epidemiology | Hip joint | Prevention | Calcium, Dietary | Calcifediol | Dosage and administration | Alfacalcidol | Health aspects | Risk factors | Index Medicus | Intervention | Vitamin D3 | Stroke | Invasiveness | Colorectal carcinoma | Mortality | Colorectal cancer | Clinical trials | Data processing | Breast cancer | Urinary tract | Coronary heart disease | Hip | Post-menopause | Cost-benefit analysis | Hip fracture | Supplementation | Cardiovascular diseases | Heart diseases | Original
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 01/2018, Volume 319, Issue 2, pp. 193 - 194
Journal Article
JAMA, ISSN 0098-7484, 07/2002, Volume 288, Issue 3, pp. 321 - 333
Journal Article